Industry

Biopharmaceutical

Sector

New drug discovery

Fiscal year end

September 30

Shares issued and outstanding

76,018,053 *

Stock purchase warrants

210,000 **

Stock options

11,330,903 **

Fully diluted

87,459,368**

Cash

$152.1 million **

Debt

Nil **

Trading symbol

AVXL

52-week range

$31.50 - $3.65 *

Financial statements and filings

Anavex's filings can be found on EDGAR

Investor relations

1-844-689-3939

ir@anavex.com

Transfer agent

Nevada Agency and Trust

50 West Liberty Street,

Suite 880

Reno, Nevada 89501

​

Tel:  (775) 322-0626

Fax: (775) 322-5623

email: info@natco.org

​

Resident Agent

email: corpserve@natco.org

Website: www.natco.org